C12N 9/6486
Renin
Official title: {Renin (3.4.23.15)}
C12N9/6486 (Renin) appears on 10 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 10
- Published applications
- 3
- Assignees
- 10
- Inventors
- 23
- Latest grant
- 27 Jan 2009
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema27 Jan 2009US 7,482,124 B2Bristol-Myers Squibb Company
- Hypotensors22 Apr 2008US 7,361,637 B2Protein Express Co., Ltd.
- Hypotensors31 May 2005US 6,900,020 B2Yuichi Ishida
- Renin-active substance12 Dec 2000US 6,159,723 ATokiwa Chemical Industries Co., Ltd.
- Prorenin antibody and renin-active substance containing the same31 Aug 1999US 5,945,512 ATokiwa Chemical Industries Co., Ltd.
Most cited
By later US patents
- Plant potyvirus expression vector with a gene for protease94US 5,162,601 AThe Upjohn Company · 1992
- Superior mammalian expression system43US 5,089,397 ACalifornia Biotechnology Inc. · 1992
- Genetically engineered bacteria to identify and produce medically important agents4US 5,532,124 AThomas Jefferson University · 1996
- Prorenin antibody and renin-active substance containing the same4US 5,945,512 ATokiwa Chemical Industries Co., Ltd. · 1999
- Transgenic mouse as model for diseases involving dopaminergic dysfunction3US 5,723,719 AHealth Research, Inc. · 1998